Coronaviruses, adept at evading host antiviral pathways induced by viral dsRNA, appear to overactivate the TLR3-related pathway, potentially exacerbating damage to patients and promoting the development of cardiovascular complications, including hypertension. This evidence concerns the gene TLR3 and hypertensive disorder.